
AstraZeneca Financially Commits $2.5B Toward New R&D Center
Combined with research and manufacturing agreements, AstraZeneca is investing $2.5 billion into its sixth global strategic research & development (R&D) center in Beijing.1 The five-year financial commitment is part of a deal with the Beijing …